Health Care Week in Review: FDA Released Its User Fee Amendments For FY 2023 – JD Supra

Alston & Bird
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.
This week, FDA released its user fee amendments for FY 2023, and CMS issued an RFI on establishing a national directory of healthcare providers and released the MA and Part D star ratings for 2023. Read more about this action and other news below.
I. Regulations, Notices & Guidance
Event Notices
II. Reports, Studies & Analyses
III. Other Health Policy News
[View source.]
See more »
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
© Alston & Bird | Attorney Advertising
Refine your interests »
This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.
Back to Top
Explore 2022 Readers’ Choice Awards
Copyright © JD Supra, LLC


Leave a Comment